Carbonic anhydrase IX-targeted H-APBC nanosystem combined with phototherapy facilitates the efficacy of PI3K/mTOR inhibitor and resists HIF-1α-dependent tumor hypoxia adaptation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbonic anhydrase IX-targeted H-APBC nanosystem combined with phototherapy facilitates the efficacy of PI3K/mTOR inhibitor and resists HIF-1α-dependent tumor hypoxia adaptation
Authors
Keywords
-
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-12
DOI
10.1186/s12951-022-01394-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The relationship between hypoxia-inducible factor 1α (HIF-1α) and patient survival in breast cancer: systematic review and meta-analysis
- (2021) Suad A.K. Shamis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- M2‐Like TAMs Function Reversal Contributes to Breast Cancer Eradication by Combination Dual Immune Checkpoint Blockade and Photothermal Therapy
- (2021) Wenrong Zhao et al. Small
- Metabolic adaptation in hypoxia and cancer
- (2021) Felipe Paredes et al. CANCER LETTERS
- Breast cancer
- (2021) Sibylle Loibl et al. LANCET
- Nanostructured Phthalocyanine Assemblies with Efficient Synergistic Effect of Type I Photoreaction and Photothermal Action to Overcome Tumor Hypoxia in Photodynamic Therapy
- (2021) Yuan-Yuan Zhao et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- ROS-augmented and tumor-microenvironment responsive biodegradable nanoplatform for enhancing chemo-sonodynamic therapy
- (2020) Jie An et al. BIOMATERIALS
- Photoactivatable Protherapeutic Nanomedicine for Cancer
- (2020) Yan Zhang et al. ADVANCED MATERIALS
- CAIXplatins: Highly Potent Platinum(IV) Prodrugs Selective Against Carbonic Anhydrase IX for the Treatment of Hypoxic Tumors
- (2020) Qian Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Dual-response oxygen-generating MnO2 nanoparticles with polydopamine modification for combined photothermal-photodynamic therapy
- (2020) Weiwei Zeng et al. CHEMICAL ENGINEERING JOURNAL
- Clinical development and potential of photothermal and photodynamic therapies for cancer
- (2020) Xingshu Li et al. Nature Reviews Clinical Oncology
- Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets
- (2020) Yue Gong et al. Cell Metabolism
- Considerations for designing preclinical cancer immune nanomedicine studies
- (2020) Wen Jiang et al. Nature Nanotechnology
- Tumor pH and metastasis: a malignant process beyond hypoxia
- (2019) Oliver Thews et al. CANCER AND METASTASIS REVIEWS
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Acidification of tumor at stromal boundaries drives transcriptome alterations associated with aggressive phenotypes
- (2019) Nazanin Rohani et al. CANCER RESEARCH
- Causes, consequences, and therapy of tumors acidosis
- (2019) Smitha R. Pillai et al. CANCER AND METASTASIS REVIEWS
- Noninvasive temperature monitoring for dual-modal tumor therapy based on lanthanide-doped up-conversion nanocomposites
- (2019) Xueke Sun et al. BIOMATERIALS
- The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
- (2019) Silvia Pastorekova et al. CANCER AND METASTASIS REVIEWS
- Intra-Tumoral Metabolic Zonation and Resultant Phenotypic Diversification Are Dictated by Blood Vessel Proximity
- (2019) Saran Kumar et al. Cell Metabolism
- mTOR: Role in cancer, metastasis and drug resistance
- (2019) Avaniyapuram Kannan Murugan SEMINARS IN CANCER BIOLOGY
- New power of self-assembling carbonic anhydrase inhibitor: Short peptide–constructed nanofibers inspire hypoxic cancer therapy
- (2019) Jiayang Li et al. Science Advances
- Amorphous Fe‐Based Nanoagents for Self‐Enhanced Chemodynamic Therapy by Re‐Establishing Tumor Acidosis
- (2019) Xiaoyan Chen et al. ADVANCED FUNCTIONAL MATERIALS
- Tumor‐Targeted Drug and CpG Delivery System for Phototherapy and Docetaxel‐Enhanced Immunotherapy with Polarization toward M1‐Type Macrophages on Triple Negative Breast Cancers
- (2019) Lv Chen et al. ADVANCED MATERIALS
- Carbonic anhydrase IX and acid transport in cancer
- (2019) Holger M. Becker BRITISH JOURNAL OF CANCER
- Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy
- (2018) Xingshu Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Phthalocyanine-Assembled Nanodots as Photosensitizers for Highly Efficient Type I Photoreactions in Photodynamic Therapy
- (2018) Xingshu Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR
- (2018) Zandra E. Walton et al. CELL
- Advances in Hypoxia-Inducible Factor Biology
- (2018) Hani Choudhry et al. Cell Metabolism
- Targeting the PI3K pathway in cancer: are we making headway?
- (2018) Filip Janku et al. Nature Reviews Clinical Oncology
- Emerging Perspectives on mTOR Inhibitor‐Associated Pneumonitis in Breast Cancer
- (2018) Ricardo H. Alvarez et al. ONCOLOGIST
- Cell-Autonomous Metabolic Reprogramming in Hypoxia
- (2018) Luana Schito et al. TRENDS IN CELL BIOLOGY
- Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages
- (2018) Toszka Bohn et al. NATURE IMMUNOLOGY
- Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis
- (2017) Elena Andreucci et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies
- (2017) Trisha M. Wise-Draper et al. Targeted Oncology
- Reprogramming of the Tumor in the Hypoxic Niche: The Emerging Concept and Associated Therapeutic Strategies
- (2017) Guan-Zhong Qiu et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer
- (2017) Luisa Iommarini et al. Frontiers in Oncology
- The ever-expanding role of HIF in tumour and stromal biology
- (2016) Edward L. LaGory et al. NATURE CELL BIOLOGY
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Acidity Generated by the Tumor Microenvironment Drives Local Invasion
- (2013) V. Estrella et al. CANCER RESEARCH
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Tumour oxygenation: implications for breast cancer prognosis
- (2013) H. Rundqvist et al. JOURNAL OF INTERNAL MEDICINE
- Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia
- (2012) Jayashree Karar et al. CANCER BIOLOGY & THERAPY
- Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
- (2011) Y. Lou et al. CANCER RESEARCH
- mTOR Kinase Inhibition Causes Feedback-Dependent Biphasic Regulation of AKT Signaling
- (2011) V. S. Rodrik-Outmezguine et al. Cancer Discovery
- Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
- (2010) Johanna Chiche et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search